Aerie Pharmaceuticals, Inc. Fair Value of Long-Term Debt
Aerie Pharmaceuticals, Inc. had Fair Value of Long-Term Debt of $299.00 million as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2018-05-09
- 2018-03-31: Long-term Debt, Fair Value $299.00M.
- 2017-12-31: Long-term Debt, Fair Value $327.60M.
- 2017-09-30: Long-term Debt, Fair Value $269.80M.
- 2017-06-30: Long-term Debt, Fair Value $287.30M.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2018-03-31 | $299.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $327.60M 10-Q · filed 2018-05-09 |
| 2017-09-30 | $269.80M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $287.30M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $255.40M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $209.60M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $211.30M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $124.20M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $92.30M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $140.10M 10-Q · filed 2016-11-03 |
| 2015-09-30 | $114.70M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $111.10M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $174.00M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $163.80M 10-Q · filed 2015-11-06 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |